Orange Book product · Generic (ANDA)
NORTRIPTYLINE HYDROCHLORIDE
NORTRIPTYLINE HYDROCHLORIDE
At a glance
Aug 15, 2023
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 15, 2023
2 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
NORTRIPTYLINE HYDROCHLORIDE
Strength
EQ 10MG BASE/5ML
Dosage form
SOLUTION
Route
ORAL
TE code
AA
Application
ANDA 217731
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NORTRIPTYLINE HYDROCHLORIDE
- —AVENTYL HYDROCHLORIDEBrand (NDA)
NDA 014684 · LILLY
- —PAMELORBrand (NDA)
NDA 018013 · SPECGX LLC
- —AVENTYLBrand (NDA)
NDA 014685 · RANBAXY
- —PAMELORBrand (NDA)
NDA 018012 · SPECGX LLC
- 2021NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213441 · ZYDUS LIFESCIENCES
- 2006NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 077965 · TARO
- 2000NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 075606 · PHARM ASSOC
- 2000NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 075520 · TARO
- 1997NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 074835 · AUROBINDO PHARMA LTD
- 1996NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 073667 · TEVA
- 1995NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 074132 · TEVA
- 1993NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 074234 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
